Obesity, GLP-1s, and the Evidence: What the Data Tells Us

Obesity, GLP-1s, and the Evidence: What the Data Tells Us

In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us

Episoder(47)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
rekommandert
sinnsyn
rss-paradigmepodden
villmarksliv
rss-nysgjerrige-norge
fjellsportpodden
tidlose-historier
diagnose
kvinnehelsepodden
rss-inn-til-kjernen-med-sunniva-rose
nevropodden
nordnorsk-historie
tomprat-med-gunnar-tjomlid
rss-overskuddsliv
rss-hoyt-lavt-med-ida-tonseth